{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:27:56Z","timestamp":1793838476187,"version":"4.6.1"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01241-3","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T01:29:12Z","timestamp":1767490152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Consensus expert recommendations for referral of Parkinson\u2019s disease patients for deep brain stimulation surgery"],"prefix":"10.1038","volume":"12","author":[{"given":"Delaram","family":"Safarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis H.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neepa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okeanis","family":"Vaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Y.","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Tolleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Hantke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh","family":"Lotia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svjetlana","family":"Miocinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhash D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Wyman-Chick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Kilbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corneliu","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai Yin","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato P.","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol De","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Sarva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Revuelta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin L.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa S.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohi","family":"Jimenez-Shahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Functional Neurosurgical working group of the Parkinson Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato P.","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol","family":"De Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"1241_CR1","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mds.29052","volume":"37","author":"P Mahlknecht","year":"2022","unstructured":"Mahlknecht, P., Foltynie, T., Limousin, P. & Poewe, W. How does deep brain stimulation change the course of Parkinson\u2019s Disease? Mov. Disord. 37, 1581\u20131592 (2022).","journal-title":"Mov. Disord."},{"key":"1241_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/17434440.2021.1909471","volume":"18","author":"J Jimenez-Shahed","year":"2021","unstructured":"Jimenez-Shahed, J. Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson\u2019s disease and related disorders. Expert Rev. Med. Devices 18, 319\u2013332 (2021).","journal-title":"Expert Rev. Med. Devices"},{"key":"1241_CR3","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.parkreldis.2025.107322","volume":"133","author":"J Jimenez-Shahed","year":"2025","unstructured":"Jimenez-Shahed, J. et al. Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson\u2019s disease. Parkinsonism Relat. Disord. 133, 107322 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1212\/CPJ.0000000000001098","volume":"11","author":"LY Cabrera","year":"2021","unstructured":"Cabrera, L. Y., Young Han, C., Ostendorf, T., Jimenez-Shahed, J. & Sarva, H. Neurologists\u2019 attitudes toward use and timing of deep brain stimulation. Neurol. Clin. Pr. 11, 506\u2013516 (2021).","journal-title":"Neurol. Clin. Pr."},{"key":"1241_CR5","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.clineuro.2021.106553","volume":"203","author":"LY Cabrera","year":"2021","unstructured":"Cabrera, L. Y. et al. Attitudes toward use and timing of deep brain stimulation: a patient\u2019s with DBS perspective. Clin. Neurol. Neurosurg. 203, 106553 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1241_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jocn.2021.11.017","volume":"95","author":"D Alfonso","year":"2022","unstructured":"Alfonso, D., Cabrera, L. Y., Sidiropoulos, C., Wang, F. & Sarva, H. How Parkinson\u2019s patients in the USA perceive deep brain stimulation in the 21st century: results of a nationwide survey. J. Clin. Neurosci. 95, 20\u201326 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"1241_CR7","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.parkreldis.2024.106982","volume":"124","author":"D Safarpour","year":"2024","unstructured":"Safarpour, D. et al. Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease. Parkinsonism Relat. Disord. 124, 106982 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR8","doi-asserted-by":"publisher","first-page":"e32829","DOI":"10.1097\/MD.0000000000032829","volume":"102","author":"Z Shang","year":"2023","unstructured":"Shang, Z. Use of Delphi in health sciences research: a narrative review. Med. (Baltim.) 102, e32829 (2023).","journal-title":"Med. (Baltim.)"},{"key":"1241_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1241_CR10","doi-asserted-by":"publisher","first-page":"106065","DOI":"10.1016\/j.parkreldis.2024.106065","volume":"123","author":"S Aslam","year":"2024","unstructured":"Aslam, S., Manfredsson, F., Stokes, A. & Shill, H. Advanced\u201d Parkinson\u2019s disease: a review. Parkinsonism Relat. Disord. 123, 106065 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR11","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1111\/ene.15386","volume":"29","author":"G Deuschl","year":"2022","unstructured":"Deuschl, G. et al. European Academy of Neurology\/Movement Disorder Society - European Section guideline on the treatment of Parkinson\u2019s disease: I. Invasive therapies. Eur. J. Neurol. 29, 2580\u20132595 (2022).","journal-title":"Eur. J. Neurol."},{"key":"1241_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41531-022-00383-y","volume":"8","author":"A Zampogna","year":"2022","unstructured":"Zampogna, A. et al. Axial impairment and falls in Parkinson\u2019s disease: 15 years of subthalamic deep brain stimulation. npj Parkinsons Dis. 8, 121 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.parkreldis.2021.12.005","volume":"94","author":"SH Lee","year":"2022","unstructured":"Lee, S. H. et al. Factors correlated with therapeutic effects of globus pallidus deep brain stimulation on freezing of gait in advanced Parkinson\u2019s disease: A pilot study. Parkinsonism Relat. Disord. 94, 111\u2013116 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/ene.13167","volume":"24","author":"C Schlenstedt","year":"2017","unstructured":"Schlenstedt, C. et al. Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson\u2019s disease: a systematic review and meta-analysis. Eur. J. Neurol. 24, 18\u201326 (2017).","journal-title":"Eur. J. Neurol."},{"key":"1241_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/mds.26712","volume":"31","author":"J Nonnekes","year":"2016","unstructured":"Nonnekes, J. et al. Unmasking levodopa resistance in Parkinson\u2019s disease. Mov. Disord. 31, 1602\u20131609 (2016).","journal-title":"Mov. Disord."},{"key":"1241_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/14737175.2022.2091436","volume":"22","author":"A Lenka","year":"2022","unstructured":"Lenka, A., Di Maria, G., Lamotte, G., Bahroo, L. & Jankovic, J. Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson\u2019s disease. Expert Rev. Neurother. 22, 489\u2013498 (2022).","journal-title":"Expert Rev. Neurother."},{"key":"1241_CR17","doi-asserted-by":"publisher","first-page":"101361","DOI":"10.1016\/j.inat.2021.101361","volume":"26","author":"A Razmkon","year":"2021","unstructured":"Razmkon, A. et al. Effect of deep brain stimulation on impulse control behaviors of Parkinson\u2019s disease patients: a systematic review and meta-analysis. Interdiscip. Neurosurg. 26, 101361 (2021).","journal-title":"Interdiscip. Neurosurg."},{"key":"1241_CR18","doi-asserted-by":"publisher","first-page":"e200345","DOI":"10.1212\/CPJ.0000000000200345","volume":"14","author":"MK Bruno","year":"2024","unstructured":"Bruno, M. K. et al. A general neurologist\u2019s practical diagnostic algorithm for atypical Parkinsonian disorders: a consensus statement. Neurol. Clin. Pr. 14, e200345 (2024).","journal-title":"Neurol. Clin. Pr."},{"key":"1241_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"1241_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mdc3.13379","volume":"9","author":"Z Lin","year":"2022","unstructured":"Lin, Z., Zhang, C., Li, D. & Sun, B. Preoperative levodopa response and deep brain stimulation effects on motor outcomes in Parkinson\u2019s Disease: a systematic review. Mov. Disord. Clin. Pr. 9, 140\u2013155 (2022).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mdc3.13825","volume":"10","author":"R Wolke","year":"2023","unstructured":"Wolke, R. et al. The role of levodopa challenge in predicting the outcome of subthalamic deep brain stimulation. Mov. Disord. Clin. Pr. 10, 1181\u20131191 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR22","doi-asserted-by":"publisher","first-page":"e187800","DOI":"10.1001\/jamanetworkopen.2018.7800","volume":"2","author":"CA Artusi","year":"2019","unstructured":"Artusi, C. A. et al. Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson Disease: a systematic review and meta-analysis. JAMA Netw. Open 2, e187800 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1241_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-019-0091-7","volume":"5","author":"J Ligaard","year":"2019","unstructured":"Ligaard, J., Sann\u00e6s, J. & Pihlstr\u00f8m, L. Deep brain stimulation and genetic variability in Parkinson\u2019s disease: a review of the literature. npj Parkinsons Dis. 5, 18 (2019).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mdc3.13994","volume":"11","author":"E Asimakidou","year":"2024","unstructured":"Asimakidou, E., Xiromerisiou, G. & Sidiropoulos, C. Motor and non-motor outcomes of deep brain stimulation across the genetic panorama of Parkinson\u2019s Disease: a multi-scale meta-analysis. Mov. Disord. Clin. Pr. 11, 465\u2013477 (2024).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3233\/JPD-171172","volume":"7","author":"V Lythe","year":"2017","unstructured":"Lythe, V. et al. GBA-associated Parkinson\u2019s Disease: progression in a deep brain stimulation cohort. J. Parkinsons Dis. 7, 635\u2013644 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR26","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/mds.25535","volume":"28","author":"A Angeli","year":"2013","unstructured":"Angeli, A. et al. Genotype and phenotype in Parkinson\u2019s disease: lessons in heterogeneity from deep brain stimulation. Mov. Disord. 28, 1370\u20131375 (2013).","journal-title":"Mov. Disord."},{"key":"1241_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1007\/s00415-012-6469-7","volume":"259","author":"D Weiss","year":"2012","unstructured":"Weiss, D. et al. Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson\u2019s disease. J. Neurol. 259, 1970\u20131972 (2012).","journal-title":"J. Neurol."},{"key":"1241_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2011","unstructured":"Lesage, S. et al. Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum. Mol. Genet 20, 202\u2013210 (2011).","journal-title":"Hum. Mol. Genet"},{"key":"1241_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bcmd.2012.11.011","volume":"50","author":"EB Chetrit","year":"2013","unstructured":"Chetrit, E. B. et al. Phenotype in patients with Gaucher disease and Parkinson disease. Blood Cells Mol. Dis. 50, 218\u2013221 (2013).","journal-title":"Blood Cells Mol. Dis."},{"key":"1241_CR30","first-page":"309","volume":"95","author":"M Avenali","year":"2024","unstructured":"Avenali, M. et al. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort. J. Neurol. Neurosurg. Psychiatry 95, 309\u2013315 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.26302","volume":"91","author":"G Pal","year":"2022","unstructured":"Pal, G. et al. Parkinson Disease and subthalamic nucleus deep brain stimulation: cognitive effects in gba mutation carriers. Ann. Neurol. 91, 424\u2013435 (2022).","journal-title":"Ann. Neurol."},{"key":"1241_CR32","doi-asserted-by":"publisher","first-page":"e214036","DOI":"10.1212\/WNL.0000000000214036","volume":"105","author":"M Avenali","year":"2025","unstructured":"Avenali, M. et al. Long-term motor and cognitive outcome of deep brain stimulation in patients with Parkinson Disease with a GBA1 pathogenic variant. Neurology 105, e214036 (2025).","journal-title":"Neurology"},{"key":"1241_CR33","doi-asserted-by":"publisher","first-page":"e0153785","DOI":"10.1371\/journal.pone.0153785","volume":"11","author":"MA Higuchi","year":"2016","unstructured":"Higuchi, M. A. et al. Interdisciplinary Parkinson\u2019s Disease deep brain stimulation screening and the relationship to unintended hospitalizations and quality of life. PLoS One 11, e0153785 (2016).","journal-title":"PLoS One"},{"key":"1241_CR34","doi-asserted-by":"publisher","unstructured":"Guidetti, M. et al. Physical therapy in patients with Parkinson\u2019s disease treated with Deep Brain Stimulation: a Delphi panel study. medRxiv. https:\/\/doi.org\/10.1101\/2024.09.20.24314037 (2024).","DOI":"10.1101\/2024.09.20.24314037"},{"key":"1241_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1044\/2022_JSLHR-22-00443","volume":"66","author":"ISB Nip","year":"2023","unstructured":"Nip, I. S. B., Burke, M. M. 3rd & Kim, Y. The effects of deep brain stimulation on speech motor control in people with Parkinson\u2019s Disease. J. Speech Lang. Hear Res 66, 804\u2013819 (2023).","journal-title":"J. Speech Lang. Hear Res"},{"key":"1241_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/mds.23664","volume":"26","author":"D Weintraub","year":"2011","unstructured":"Weintraub, D. & Burn, D. J. Parkinson\u2019s disease: the quintessential neuropsychiatric disorder. Mov. Disord. 26, 1022\u20131031 (2011).","journal-title":"Mov. Disord."},{"key":"1241_CR37","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/arclin\/acx090","volume":"32","author":"AI Tr\u00f6ster","year":"2017","unstructured":"Tr\u00f6ster, A. I. Some clinically useful information that neuropsychology provides patients, carepartners, neurologists, and neurosurgeons about deep brain stimulation for Parkinson\u2019s Disease. Arch. Clin. Neuropsychol. 32, 810\u2013828 (2017).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1241_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/mdc3.12592","volume":"5","author":"M Rossi","year":"2018","unstructured":"Rossi, M., Bruno, V., Arena, J., Cammarota, \u00c1 & Merello, M. Challenges in PD patient management after DBS: a pragmatic review. Mov. Disord. Clin. Pr. 5, 246\u2013254 (2018).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR39","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/mdc3.13660","volume":"10","author":"CK Block","year":"2023","unstructured":"Block, C. K. et al. Patients with cognitive impairment in Parkinson\u2019s Disease benefit from deep brain stimulation: a case-control study. Mov. Disord. Clin. Pr. 10, 382\u2013391 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1017\/S1355617716000035","volume":"22","author":"KA Wyman-Chick","year":"2016","unstructured":"Wyman-Chick, K. A. Verbal fluency in Parkinson\u2019s Patients with and without bilateral deep brain stimulation of the subthalamic nucleus: a meta-analysis. J. Int Neuropsychol. Soc. 22, 478\u2013485 (2016).","journal-title":"J. Int Neuropsychol. Soc."},{"key":"1241_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2016.09.018","volume":"33","author":"JA Boel","year":"2016","unstructured":"Boel, J. A. et al. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease. Parkinsonism Relat. Disord. 33, 90\u201395 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR42","doi-asserted-by":"publisher","first-page":"e0302739","DOI":"10.1371\/journal.pone.0302739","volume":"19","author":"F Tabari","year":"2024","unstructured":"Tabari, F. et al. Speech, voice, and language outcomes following deep brain stimulation: a systematic review. PLoS One 19, e0302739 (2024).","journal-title":"PLoS One"},{"key":"1241_CR43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ana.26903","volume":"95","author":"VA Del Bene","year":"2024","unstructured":"Del Bene, V. A. et al. Differential cognitive effects of unilateral subthalamic nucleus deep brain stimulation for Parkinson\u2019s Disease. Ann. Neurol. 95, 1205\u20131219 (2024).","journal-title":"Ann. Neurol."},{"key":"1241_CR44","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1002\/mdc3.13921","volume":"10","author":"F Rodriguez-Porcel","year":"2023","unstructured":"Rodriguez-Porcel, F., Schwen Blackett, D., Hickok, G., Bonilha, L. & Turner, T. H. Bridging the gap: association between objective and subjective outcomes of communication performance in people with Parkinson\u2019s Disease evaluated for deep brain stimulation. Mov. Disord. Clin. Pr. 10, 1795\u20131799 (2023).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR45","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/anae.16398","volume":"79","author":"C Diep","year":"2024","unstructured":"Diep, C. et al. Incidence and relative risk of delirium after major surgery for patients with pre-operative depression: a systematic review and meta-analysis. Anaesthesia 79, 1237\u20131249 (2024).","journal-title":"Anaesthesia"},{"key":"1241_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41531-024-00701-6","volume":"10","author":"A Sauerbier","year":"2024","unstructured":"Sauerbier, A. et al. Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson\u2019s disease. npj Parkinsons Dis. 10, 114 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fneur.2019.00617","volume":"10","author":"EA Accolla","year":"2019","unstructured":"Accolla, E. A. & Pollo, C. Mood effects after deep brain stimulation for parkinson\u2019s disease: an update. Front Neurol. 10, 617 (2019).","journal-title":"Front Neurol."},{"key":"1241_CR48","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub, D. et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch. Neurol. 63, 969\u2013973 (2006).","journal-title":"Arch. Neurol."},{"key":"1241_CR49","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"V Voon","year":"2006","unstructured":"Voon, V. et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 66, 1750\u20131752 (2006).","journal-title":"Neurology"},{"key":"1241_CR50","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1136\/jnnp-2013-307214","volume":"86","author":"P Amami","year":"2015","unstructured":"Amami, P. et al. Impulse control behaviours in patients with Parkinson\u2019s disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up. J. Neurol. Neurosurg. Psychiatry 86, 562\u2013564 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4103\/0028-3886.44830","volume":"56","author":"P Doshi","year":"2008","unstructured":"Doshi, P. & Bhargava, P. Hypersexuality following subthalamic nucleus stimulation for Parkinson\u2019s disease. Neurol. India 56, 474\u2013476 (2008).","journal-title":"Neurol. India"},{"key":"1241_CR52","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/brain\/aws078","volume":"135","author":"E Lhomm\u00e9e","year":"2012","unstructured":"Lhomm\u00e9e, E. et al. Subthalamic stimulation in Parkinson\u2019s disease: restoring the balance of motivated behaviours. Brain 135, 1463\u20131477 (2012).","journal-title":"Brain"},{"key":"1241_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.parkreldis.2011.02.013","volume":"17","author":"M Broen","year":"2011","unstructured":"Broen, M., Duits, A., Visser-Vandewalle, V., Temel, Y. & Winogrodzka, A. Impulse control and related disorders in Parkinson\u2019s disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat. Disord. 17, 413\u2013417 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.parkreldis.2011.08.016","volume":"18","author":"P Shotbolt","year":"2012","unstructured":"Shotbolt, P. et al. Relationships between deep brain stimulation and impulse control disorders in Parkinson\u2019s disease, with a literature review. Parkinsonism Relat. Disord. 18, 10\u201316 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR55","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mds.26099","volume":"30","author":"M Samuel","year":"2015","unstructured":"Samuel, M. et al. Management of impulse control disorders in Parkinson\u2019s disease: controversies and future approaches. Mov. Disord. 30, 150\u2013159 (2015).","journal-title":"Mov. Disord."},{"key":"1241_CR56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub, D. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch. Neurol. 67, 589\u2013595 (2010).","journal-title":"Arch. Neurol."},{"key":"1241_CR57","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/brain\/awn214","volume":"131","author":"V Voon","year":"2008","unstructured":"Voon, V. et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson\u2019s disease. Brain 131, 2720\u20132728 (2008).","journal-title":"Brain"},{"key":"1241_CR58","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/jnnp-2012-304396","volume":"84","author":"D Weintraub","year":"2013","unstructured":"Weintraub, D. et al. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson\u2019s disease: results from a randomised, controlled trial. J. Neurol. Neurosurg. Psychiatry 84, 1113\u20131118 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1241_CR59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res"},{"key":"1241_CR60","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1241_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/arclin\/12.3.269","volume":"12","author":"DC Marson","year":"1997","unstructured":"Marson, D. C., Dymek, M. P., Duke, L. W. & Harrell, L. E. Subscale validity of the Mattis Dementia Rating Scale. Arch. Clin. Neuropsychol. 12, 269\u2013275 (1997).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1241_CR62","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.parkreldis.2017.05.003","volume":"41","author":"M Fabbri","year":"2017","unstructured":"Fabbri, M. et al. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 41, 113\u2013117 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR63","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/bs.irn.2017.05.022","volume":"134","author":"E Hogg","year":"2017","unstructured":"Hogg, E., Wertheimer, J., Graner, S. & Tagliati, M. Deep brain stimulation and nonmotor symptoms. Int Rev. Neurobiol. 134, 1045\u20131089 (2017).","journal-title":"Int Rev. Neurobiol."},{"key":"1241_CR64","doi-asserted-by":"publisher","first-page":"1397344","DOI":"10.3389\/fneur.2024.1397344","volume":"15","author":"L Gao","year":"2024","unstructured":"Gao, L., Wang, M., Zhou, M., Yin, W. & Cao, X. Impact of deep brain stimulation on urogenital function in Parkinson\u2019s disease: a systematic review and meta-analysis. Front Neurol. 15, 1397344 (2024).","journal-title":"Front Neurol."},{"key":"1241_CR65","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3171\/2023.7.JNS23837","volume":"140","author":"A Askari","year":"2024","unstructured":"Askari, A. et al. Impact of subthalamic nucleus stimulation on urinary dysfunction and constipation in Parkinson\u2019s disease. J. Neurosurg. 140, 657\u2013664 (2024).","journal-title":"J. Neurosurg."},{"key":"1241_CR66","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/02688697.2019.1639617","volume":"34","author":"Z Bunjo","year":"2020","unstructured":"Bunjo, Z., Bacchi, S., Chandran, A. S. & Zacest, A. Orthostatic hypotension following deep brain stimulation in parkinson\u2019s disease: a systematic review. Br. J. Neurosurg. 34, 587\u2013590 (2020).","journal-title":"Br. J. Neurosurg."},{"key":"1241_CR67","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1177\/08919887211060017","volume":"35","author":"D Nimmons","year":"2022","unstructured":"Nimmons, D., Bhanu, C., Orlu, M., Schrag, A. & Walters, K. Orthostatic hypotension and antiparkinsonian drugs: a systematic review and meta-analysis. J. Geriatr. Psychiatry Neurol. 35, 639\u2013654 (2022).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"1241_CR68","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JPD-191862","volume":"10","author":"JRP Zuzu\u00e1rregui","year":"2020","unstructured":"Zuzu\u00e1rregui, J. R. P. & Ostrem, J. L. The impact of deep brain stimulation on sleep in Parkinson\u2019s Disease: an update. J. Parkinsons Dis. 10, 393\u2013404 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR69","doi-asserted-by":"publisher","first-page":"e34509","DOI":"10.1097\/MD.0000000000034509","volume":"102","author":"K Zhu","year":"2023","unstructured":"Zhu, K., Peng, S., Wu, Y., Zhao, Y. & Lu, Z. Deep brain stimulation of the subthalamic nucleus improves sleep in Parkinson disease patients: A systematic review and meta-analysis. Medicine 102, e34509 (2023).","journal-title":"Medicine"},{"key":"1241_CR70","doi-asserted-by":"publisher","first-page":"1269864","DOI":"10.3389\/fnhum.2023.1269864","volume":"17","author":"AA Memon","year":"2023","unstructured":"Memon, A. A. et al. Effects of deep brain stimulation on quantitative sleep electroencephalogram during non-rapid eye movement in Parkinson\u2019s disease. Front. Hum. Neurosci. 17, 1269864 (2023).","journal-title":"Front. Hum. Neurosci."},{"key":"1241_CR71","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1093\/brain\/awz285","volume":"142","author":"JN Petry-Schmelzer","year":"2019","unstructured":"Petry-Schmelzer, J. N. et al. Non-motor outcomes depend on location of neurostimulation in Parkinson\u2019s disease. Brain 142, 3592\u20133604 (2019).","journal-title":"Brain"},{"key":"1241_CR72","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.brs.2020.09.019","volume":"13","author":"HS Dafsari","year":"2020","unstructured":"Dafsari, H. S. et al. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson\u2019s disease. Brain Stimul. 13, 1697\u20131705 (2020).","journal-title":"Brain Stimul."},{"key":"1241_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11910-018-0828-4","volume":"18","author":"B Deb\u00fb","year":"2018","unstructured":"Deb\u00fb, B., De Oliveira Godeiro, C., Lino, J. C. & Moro, E. Managing gait, balance, and posture in Parkinson\u2019s Disease. Curr. Neurol. Neurosci. Rep. 18, 23 (2018).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"1241_CR74","doi-asserted-by":"publisher","first-page":"688760","DOI":"10.3389\/fneur.2021.688760","volume":"12","author":"H Brozova","year":"2021","unstructured":"Brozova, H. et al. Short- and long-term effects of DBS on gait in Parkinson\u2019s Disease. Front Neurol. 12, 688760 (2021).","journal-title":"Front Neurol."},{"key":"1241_CR75","doi-asserted-by":"publisher","first-page":"e000898","DOI":"10.1136\/bmjno-2024-000898","volume":"7","author":"JM Janssen Daalen","year":"2025","unstructured":"Janssen Daalen, J. M. et al. Gait and balance worsening after bilateral deep brain stimulation of the subthalamic nucleus (STN-DBS) for Parkinson\u2019s disease: a systematic review. BMJ Neurol. Open 7, e000898 (2025).","journal-title":"BMJ Neurol. Open"},{"key":"1241_CR76","doi-asserted-by":"publisher","unstructured":"Tueth, L. E. et al. Physical Therapy and Deep Brain Stimulation in Parkinson Disease: Safety, Feasibility, and Preliminary Efficacy. J Neurol Phys Ther. https:\/\/doi.org\/10.1097\/npt.0000000000000519 (2025).","DOI":"10.1097\/npt.0000000000000519"},{"key":"1241_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/02688697.2022.2077308","volume":"37","author":"A Razmkon","year":"2023","unstructured":"Razmkon, A., Abdollahifard, S., Taherifard, E., Roshanshad, A. & Shahrivar, K. Effect of deep brain stimulation on freezing of gait in patients with Parkinson\u2019s disease: a systematic review. Br. J. Neurosurg. 37, 3\u201311 (2023).","journal-title":"Br. J. Neurosurg."},{"key":"1241_CR78","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.26545","volume":"31","author":"V Fleury","year":"2016","unstructured":"Fleury, V. et al. Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Mov. Disord. 31, 1389\u20131397 (2016).","journal-title":"Mov. Disord."},{"key":"1241_CR79","doi-asserted-by":"publisher","unstructured":"Di Rauso, G. et al. Freezing of gait in Parkinson\u2019s Disease patients treated with bilateral subthalamic nucleus deep brain stimulation: a long-term overview. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10092214 (2022).","DOI":"10.3390\/biomedicines10092214"},{"key":"1241_CR80","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3171\/2012.8.JNS112006","volume":"117","author":"L Rocchi","year":"2012","unstructured":"Rocchi, L. et al. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J. Neurosurg. 117, 1141\u20131149 (2012).","journal-title":"J. Neurosurg."},{"key":"1241_CR81","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mds.27892","volume":"35","author":"MT Barbe","year":"2020","unstructured":"Barbe, M. T. et al. Deep brain stimulation for freezing of gait in Parkinson\u2019s Disease with early motor complications. Mov. Disord. 35, 82\u201390 (2020).","journal-title":"Mov. Disord."},{"key":"1241_CR82","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.parkreldis.2019.01.021","volume":"62","author":"C Karachi","year":"2019","unstructured":"Karachi, C. et al. Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson\u2019s disease patients. Parkinsonism Relat. Disord. 62, 91\u201397 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR83","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41531-023-00600-2","volume":"9","author":"T Herman","year":"2023","unstructured":"Herman, T. et al. A meta-analysis identifies factors predicting the future development of freezing of gait in Parkinson\u2019s disease. npj Parkinsons Dis. 9, 158 (2023).","journal-title":"npj Parkinsons Dis."},{"key":"1241_CR84","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/mds.25677","volume":"28","author":"M P\u00f6tter-Nerger","year":"2013","unstructured":"P\u00f6tter-Nerger, M. & Volkmann, J. Deep brain stimulation for gait and postural symptoms in Parkinson\u2019s disease. Mov. Disord. 28, 1609\u20131615 (2013).","journal-title":"Mov. Disord."},{"key":"1241_CR85","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/01945998221120189","volume":"168","author":"R Baudouin","year":"2023","unstructured":"Baudouin, R. et al. Deep brain stimulation impact on voice and speech quality in Parkinson\u2019s Disease: a systematic review. Otolaryngol. Head. Neck Surg. 168, 307\u2013318 (2023).","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"1241_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-017-1676-0","volume":"124","author":"L Brabenec","year":"2017","unstructured":"Brabenec, L., Mekyska, J., Galaz, Z. & Rektorova, I. Speech disorders in Parkinson\u2019s disease: early diagnostics and effects of medication and brain stimulation. J. Neural Transm. 124, 303\u2013334 (2017).","journal-title":"J. Neural Transm."},{"key":"1241_CR87","doi-asserted-by":"publisher","first-page":"1383714","DOI":"10.3389\/fnhum.2024.1383714","volume":"18","author":"JL Manes","year":"2024","unstructured":"Manes, J. L. et al. A neurocomputational view of the effects of Parkinson\u2019s disease on speech production. Front Hum. Neurosci. 18, 1383714 (2024).","journal-title":"Front Hum. Neurosci."},{"key":"1241_CR88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","volume":"31","author":"I Suttrup","year":"2016","unstructured":"Suttrup, I. & Warnecke, T. Dysphagia in Parkinson\u2019s Disease. Dysphagia 31, 24\u201332 (2016).","journal-title":"Dysphagia"},{"key":"1241_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40265-021-01664-1","volume":"82","author":"D Safarpour","year":"2022","unstructured":"Safarpour, D., Sharzehi, K. & Pfeiffer, R. F. Gastrointestinal dysfunction in Parkinson\u2019s Disease. Drugs 82, 169\u2013197 (2022).","journal-title":"Drugs"},{"key":"1241_CR90","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1055\/s-0043-1771461","volume":"43","author":"L Talman","year":"2023","unstructured":"Talman, L. & Safarpour, D. An overview of gastrointestinal dysfunction in Parkinsonian syndromes. Semin Neurol. 43, 583\u2013597 (2023).","journal-title":"Semin Neurol."},{"key":"1241_CR91","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/mds.25259","volume":"27","author":"AK Silbergleit","year":"2012","unstructured":"Silbergleit, A. K. et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson\u2019s disease. Mov. Disord. 27, 1763\u20131768 (2012).","journal-title":"Mov. Disord."},{"key":"1241_CR92","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.parkreldis.2013.05.001","volume":"19","author":"MS Troche","year":"2013","unstructured":"Troche, M. S., Brandimore, A. E., Foote, K. D. & Okun, M. S. Swallowing and deep brain stimulation in Parkinson\u2019s disease: a systematic review. Parkinsonism Relat. Disord. 19, 783\u2013788 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mds.29282","volume":"38","author":"S Pinto","year":"2023","unstructured":"Pinto, S. et al. Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson\u2019s Disease. Mov. Disord. 38, 212\u2013222 (2023).","journal-title":"Mov. Disord."},{"key":"1241_CR94","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1474-4422(18)30239-4","volume":"17","author":"R Katzenschlager","year":"2018","unstructured":"Katzenschlager, R. et al. Apomorphine subcutaneous infusion in patients with Parkinson\u2019s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 17, 749\u2013759 (2018).","journal-title":"Lancet Neurol."},{"key":"1241_CR95","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1474-4422(22)00400-8","volume":"21","author":"MJ Soileau","year":"2022","unstructured":"Soileau, M. J. et al. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson\u2019s disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol. 21, 1099\u20131109 (2022).","journal-title":"Lancet Neurol."},{"key":"1241_CR96","doi-asserted-by":"publisher","first-page":"e16582","DOI":"10.1111\/ene.16582","volume":"32","author":"M \u00d6thman","year":"2025","unstructured":"\u00d6thman, M. et al. Levodopa-entacapone-carbidopa intestinal gel: data from the Swedish national registry for Parkinson\u2019s disease. Eur. J. Neurol. 32, e16582 (2025).","journal-title":"Eur. J. Neurol."},{"key":"1241_CR97","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3389\/fneur.2018.00620","volume":"9","author":"L Wang","year":"2018","unstructured":"Wang, L., Li, J. & Chen, J. Levodopa-carbidopa intestinal gel in Parkinson\u2019s Disease: a systematic review and meta-analysis. Front. Neurol. 9, 620 (2018).","journal-title":"Front. Neurol."},{"key":"1241_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","volume":"13","author":"CW Olanow","year":"2014","unstructured":"Olanow, C. W. et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol. 13, 141\u2013149 (2014).","journal-title":"Lancet Neurol."},{"key":"1241_CR99","doi-asserted-by":"publisher","unstructured":"Nyholm, D. & Jost, W. H. Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson\u2019s disease: real-world experience and practical guidance. Ther Adv Neurol Disord 15, 17562864221108018. https:\/\/doi.org\/10.1177\/17562864221108018 (2022).","DOI":"10.1177\/17562864221108018"},{"key":"1241_CR100","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/JPD-225112","volume":"13","author":"T van Laar","year":"2023","unstructured":"van Laar, T., Chaudhuri, K. R., Antonini, A., Henriksen, T. & Tro\u0161t, M. Infusion therapies in the treatment of Parkinson\u2019s Disease. J. Parkinsons Dis. 13, 641\u2013657 (2023).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR101","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/WNF.0000000000000216","volume":"40","author":"I Regidor","year":"2017","unstructured":"Regidor, I., Benita, V., Del \u00c1lamo de Pedro, M., Ley, L. & Martinez Castrillo, J. C. Duodenal levodopa infusion for long-term deep brain stimulation-refractory symptoms in advanced Parkinson's disease. Clin. Neuropharmacol. 40, 103\u2013107 (2017).","journal-title":"Clin. Neuropharmacol."},{"key":"1241_CR102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.parkreldis.2014.12.012","volume":"21","author":"A Antonini","year":"2015","unstructured":"Antonini, A., Yegin, A., Preda, C., Bergmann, L. & Poewe, W. Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson\u2019s disease patients; 12-month interim outcomes. Parkinsonism Relat. Disord. 21, 231\u2013235 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR103","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/ner.12474","volume":"19","author":"JB Pietzsch","year":"2016","unstructured":"Pietzsch, J. B., Garner, A. M. & Marks, W. J. Jr Cost-Effectiveness of deep brain stimulation for advanced parkinson\u2019s disease in the United States. Neuromodulation 19, 689\u2013697 (2016).","journal-title":"Neuromodulation"},{"key":"1241_CR104","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3233\/JPD-202348","volume":"11","author":"K Smilowska","year":"2021","unstructured":"Smilowska, K. et al. Cost-effectiveness of device-aided therapies in parkinson\u2019s disease: a structured review. J. Parkinsons Dis. 11, 475\u2013489 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1241_CR105","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.parkreldis.2009.09.005","volume":"15","author":"CE Clarke","year":"2009","unstructured":"Clarke, C. E., Worth, P., Grosset, D. & Stewart, D. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson\u2019s disease. Parkinsonism Relat. Disord. 15, 728\u2013741 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR106","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","volume":"23","author":"AJ Espay","year":"2024","unstructured":"Espay, A. J. et al. Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial. Lancet Neurol. 23, 465\u2013476 (2024).","journal-title":"Lancet Neurol."},{"key":"1241_CR107","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00415-017-8477-0","volume":"264","author":"\u00c1 Sesar","year":"2017","unstructured":"Sesar, \u00c1, Fern\u00e1ndez-Pajar\u00edn, G., Ares, B., Rivas, M. T. & Castro, A. Continuous subcutaneous apomorphine infusion in advanced Parkinson\u2019s disease: 10-year experience with 230 patients. J. Neurol. 264, 946\u2013954 (2017).","journal-title":"J. Neurol."},{"key":"1241_CR108","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.27338","volume":"33","author":"HH Fernandez","year":"2018","unstructured":"Fernandez, H. H. et al. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease. Mov. Disord. 33, 928\u2013936 (2018).","journal-title":"Mov. Disord."},{"key":"1241_CR109","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.21936","volume":"23","author":"S Farris","year":"2008","unstructured":"Farris, S., Vitek, J. & Giroux, M. L. Deep brain stimulation hardware complications: the role of electrode impedance and current measurements. Mov. Disord. 23, 755\u2013760 (2008).","journal-title":"Mov. Disord."},{"key":"1241_CR110","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1001\/archneur.62.8.noc40425","volume":"62","author":"MS Okun","year":"2005","unstructured":"Okun, M. S. et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch. Neurol. 62, 1250\u20131255 (2005).","journal-title":"Arch. Neurol."},{"key":"1241_CR111","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3171\/2018.1.JNS171660","volume":"130","author":"LA Frizon","year":"2019","unstructured":"Frizon, L. A. et al. Outcomes following deep brain stimulation lead revision or reimplantation for Parkinson\u2019s disease. J. Neurosurg. 130, 1841\u20131846 (2019).","journal-title":"J. Neurosurg."},{"key":"1241_CR112","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2013.8.FOCUS13293","volume":"35","author":"KJ Bulluss","year":"2013","unstructured":"Bulluss, K. J., Pereira, E. A., Joint, C. & Aziz, T. Z. Pallidotomy after chronic deep brain stimulation. Neurosurg. Focus 35, E5 (2013).","journal-title":"Neurosurg. Focus"},{"key":"1241_CR113","doi-asserted-by":"publisher","unstructured":"Nagy, A. M. & Tolleson, C. M. Rescue Procedures after Suboptimal Deep Brain Stimulation Outcomes in Common Movement Disorders. Brain Sci 6. https:\/\/doi.org\/10.3390\/brainsci6040046 (2016).","DOI":"10.3390\/brainsci6040046"},{"key":"1241_CR114","doi-asserted-by":"publisher","unstructured":"Chen, S. C., Bluhm, R., Achtyes, E. D., McCright, A. M. & Cabrera, L. Y. Looking through the lens of stigma: Understanding and anticipating concerns about the responsible development and use of psychiatric electroceutical interventions (PEIs). SSM Ment Health 4. https:\/\/doi.org\/10.1016\/j.ssmmh.2023.100261 (2023).","DOI":"10.1016\/j.ssmmh.2023.100261"},{"key":"1241_CR115","doi-asserted-by":"publisher","first-page":"605959","DOI":"10.3389\/fneur.2021.605959","volume":"12","author":"S Das","year":"2021","unstructured":"Das, S. et al. Capturing initial understanding and impressions of surgical therapy for Parkinson\u2019s Disease. Front Neurol. 12, 605959 (2021).","journal-title":"Front Neurol."},{"key":"1241_CR116","first-page":"1939831","volume":"2017","author":"M Sperens","year":"2017","unstructured":"Sperens, M., Hamberg, K. & Hariz, G. M. Are Patients Ready for \u201cEARLYSTIM\u201d? Attitudes towards Deep Brain Stimulation among Female and Male Patients with Moderately Advanced Parkinson\u2019s Disease. Parkinsons Dis. 2017, 1939831 (2017).","journal-title":"Parkinsons Dis."},{"key":"1241_CR117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.parkreldis.2015.11.010","volume":"23","author":"MR Kim","year":"2016","unstructured":"Kim, M. R. et al. Patients\u2019 reluctance to undergo deep brain stimulation for Parkinson\u2019s disease. Parkinsonism Relat. Disord. 23, 91\u201394 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1241_CR118","doi-asserted-by":"publisher","unstructured":"Cabrera, L. Y., Kelly-Blake, K. & Sidiropoulos, C. Perspectives on Deep Brain Stimulation and Its Earlier Use for Parkinson\u2019s Disease: a qualitative study of US Patients. Brain Sci 10. https:\/\/doi.org\/10.3390\/brainsci10010034 (2020).","DOI":"10.3390\/brainsci10010034"},{"key":"1241_CR119","first-page":"9360354","volume":"2017","author":"CD Knoop","year":"2017","unstructured":"Knoop, C. D. et al. Bridging the gaps in patient education for DBS surgery in Parkinson\u2019s Disease. Parkinsons Dis. 2017, 9360354 (2017).","journal-title":"Parkinsons Dis."},{"key":"1241_CR120","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000538748","volume":"102","author":"AE Bishay","year":"2024","unstructured":"Bishay, A. E. et al. Disparities in access to deep brain stimulation for Parkinson\u2019s Disease and proposed interventions: a literature review. Stereotact. Funct. Neurosurg. 102, 179\u2013194 (2024).","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"1241_CR121","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/mdc3.14284","volume":"12","author":"ME Fullard","year":"2025","unstructured":"Fullard, M. E. et al. How women and men with Parkinson\u2019s Disease approach decision-making for deep brain stimulation surgery. Mov. Disord. Clin. Pr. 12, 453\u2013463 (2025).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR122","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1212\/WNL.0000000000012246","volume":"97","author":"F Bove","year":"2021","unstructured":"Bove, F. et al. Long-term Outcomes (15 Years) after subthalamic nucleus deep brain stimulation in patients with Parkinson Disease. Neurology 97, e254\u2013e262 (2021).","journal-title":"Neurology"},{"key":"1241_CR123","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1212\/WNL.0000000000009946","volume":"95","author":"ML Hacker","year":"2020","unstructured":"Hacker, M. L. et al. Deep brain stimulation in early-stage Parkinson disease: five-year outcomes. Neurology 95, e393\u2013e401 (2020).","journal-title":"Neurology"},{"key":"1241_CR124","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/mdc3.13015","volume":"7","author":"V Stoker","year":"2020","unstructured":"Stoker, V. et al. Deep brain stimulation impact on social and occupational functioning in Parkinson\u2019s Disease with early motor complications. Mov. Disord. Clin. Pr. 7, 672\u2013680 (2020).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"1241_CR125","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/ner.12608","volume":"20","author":"M Eijkholt","year":"2017","unstructured":"Eijkholt, M., Cabrera, L. Y., Ramirez-Zamora, A. & Pilitsis, J. G. Shaking Up the Debate: ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson\u2019s Patients. Neuromodulation 20, 411\u2013416 (2017).","journal-title":"Neuromodulation"},{"key":"1241_CR126","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00702-023-02680-z","volume":"130","author":"F Borove\u010dki","year":"2023","unstructured":"Borove\u010dki, F. et al. Are Parkinson\u2019s disease patients referred too late for device-aided therapies and how can better informed and earlier referrals be encouraged? J. Neural Transm. 130, 1405\u20131409 (2023).","journal-title":"J. Neural Transm."},{"key":"1241_CR127","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1212\/WNL.0000000000003485","volume":"88","author":"CS Kubu","year":"2017","unstructured":"Kubu, C. S. et al. Insights gleaned by measuring patients\u2019 stated goals for DBS: more than tremor. Neurology 88, 124\u2013130 (2017).","journal-title":"Neurology"},{"key":"1241_CR128","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10143-024-02948-2","volume":"47","author":"JDS Monteiro","year":"2024","unstructured":"Monteiro, J. D. S. et al. Magnetic resonance-guided focused ultrasound ventral intermediate thalamotomy for tremor-dominant Parkinson\u2019s disease: a systematic review and meta-analysis. Neurosurg. Rev. 47, 701 (2024).","journal-title":"Neurosurg. Rev."},{"key":"1241_CR129","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.nrl.2020.05.014","volume":"38","author":"JR P\u00e9rez-S\u00e1nchez","year":"2023","unstructured":"P\u00e9rez-S\u00e1nchez, J. R. et al. Gamma Knife\u00ae stereotactic radiosurgery as a treatment for essential and parkinsonian tremor: long-term experience. Neurologia 38, 188\u2013196 (2023).","journal-title":"Neurologia"},{"key":"1241_CR130","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2202721","volume":"388","author":"V Krishna","year":"2023","unstructured":"Krishna, V. et al. Trial of globus pallidus focused ultrasound ablation in Parkinson\u2019s Disease. N. Engl. J. Med 388, 683\u2013693 (2023).","journal-title":"N. Engl. J. Med"},{"key":"1241_CR131","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1056\/NEJMoa2016311","volume":"383","author":"R Mart\u00ednez-Fern\u00e1ndez","year":"2020","unstructured":"Mart\u00ednez-Fern\u00e1ndez, R. et al. Randomized trial of focused ultrasound subthalamotomy for Parkinson\u2019s Disease. N. Engl. J. Med 383, 2501\u20132513 (2020).","journal-title":"N. Engl. J. Med"},{"key":"1241_CR132","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fsurg.2019.00076","volume":"6","author":"MN Gallay","year":"2019","unstructured":"Gallay, M. N. et al. MRgFUS pallidothalamic tractotomy for chronic therapy-resistant Parkinson\u2019s Disease in 51 consecutive patients: single center experience. Front. Surg. 6, 76 (2019).","journal-title":"Front. Surg."},{"key":"1241_CR133","doi-asserted-by":"publisher","first-page":"601153","DOI":"10.3389\/fneur.2021.601153","volume":"12","author":"MN Gallay","year":"2021","unstructured":"Gallay, M. N., Moser, D., Magara, A. E., Haufler, F. & Jeanmonod, D. Bilateral MR-guided focused ultrasound pallidothalamic tractotomy for Parkinson\u2019s Disease with 1-year follow-up. Front. Neurol. 12, 601153 (2021).","journal-title":"Front. Neurol."},{"key":"1241_CR134","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/mds.26625","volume":"32","author":"Y Higuchi","year":"2017","unstructured":"Higuchi, Y., Matsuda, S. & Serizawa, T. Gamma knife radiosurgery in movement disorders: Indications and limitations. Mov. Disord. 32, 28\u201335 (2017).","journal-title":"Mov. Disord."},{"key":"1241_CR135","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3171\/jns.2001.94.6.0899","volume":"94","author":"LS Chin","year":"2001","unstructured":"Chin, L. S., Ma, L. & DiBiase, S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J. Neurosurg. 94, 899\u2013904 (2001).","journal-title":"J. Neurosurg."},{"key":"1241_CR136","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3171\/2023.7.JNS222744","volume":"140","author":"T Wirth","year":"2024","unstructured":"Wirth, T. et al. Clinical outcomes after MRI connectivity-guided radiofrequency thalamotomy for tremor. J. Neurosurg. 140, 1148\u20131154 (2024).","journal-title":"J. Neurosurg."},{"key":"1241_CR137","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000506999","volume":"98","author":"RWJ Pauwels","year":"2020","unstructured":"Pauwels, R. W. J., Oterdoom, D. L. M., Drost, G., van Laar, T. & van Dijk, J. M. C. Long-term patient-reported outcome of radiofrequency thalamotomy for tremor. Stereotact. Funct. Neurosurg. 98, 187\u2013192 (2020).","journal-title":"Stereotact. Funct. Neurosurg."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01241-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:28:54Z","timestamp":1769527734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1241"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01241-3","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DS: Reports research support from Medtronic, Boston Scientific, CND Life Science and Amneal and payments for advisory boards from Medtronic, BlueRock, Acadia and Insightec, and Boston Scientific, and teaching from Boston Scientific. MS: Received clinical trial support from Abbvie, Supernus, Bial, UCB, Scion. Received consulting fees from Boston Scientific and Medtronic.CS: Reports acting as a consultant for PD NeurotechnologyTHT: Consultant for clinical trials in movement disorders for Clario (previously WCG)KWC, LC: No relevant disclosures CT: No relevant disclosures.VDS: Received educational funds from Medtronic, unrelated to the submitted work.LA: Consultant for Medtronic and Boston Scientific.CA: Received research support from the Hotchkiss Brain Institute, the Calgary Parkinson Research Initiative, and the Quebec Consortium for Drug Discovery. She served as a consultant for Synucure Therapeutics; and received honoraria from the International Parkinson and Movement Disorder Society (MDS).AF received payments as consultant and\/or speaker from Abbvie, Abbott, Boston Scientific, Ceregate, Inbrain Neuroelectronics, Medtronic, Iota; he has received research support from Abbvie, Boston Scientific, Medtronic.MSS has received honoraria as consultant\/scientific advisory board member from Boston Scientific Neuromodulation and Medtronic. He has received research grants on behalf of the institution from Boston Scientific Neuromodulation, Abbvie, Biogen, Neuraly, Michael J Fox Foundation, National Institute of Health, NP: has received honoraria as a consultant for Abbvie, Superneus, Amneal. CK: has served as consultant and or speaker for Medtronic and Teva. JJS: has received consulting fees from Medtronic, BlueRock, Teva, Abbvie, Amneal; serves on the scientific advisory board for Photopharmics and RebrAIn, and on the DSMB for Biohaven and Emalex; and has received research funds from BlueRock and ONO. TMH has received consulting fees from Medtronic, serves on the scientific advisory board for Medtronic and MarvelBiome, serves on the DSMB for BlueRock Therapeutics, and has received research support from Medtronic, Boston Scientific and AskBio.HS has received clinical trial support from Novo Nordisk, Blue Rock, Prevail, MeiraGTX, Insightec, Biogen, Genentech, Bukwang, Neuroderm, Sun Pharma, Cerevance, UCB, Bial. She has received consulting fees from Novo Nordisk. HO has received clinical trial support from Novo Nordisk, Blue Rock, Prevail, MeiraGTX, Insightec, Biogen, Genentech, Bukwang, Sun Pharma, Cerevance, UCB, Bial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}